✦ LIBER ✦

Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore

✍ Scribed by Ann S.G. Lee; G.H. Ho; P.C. Oh; C. Balram; L.L. Ooi; D.T.H. Lim; C.Y. Wong; G.S. Hong

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 48 KB
Volume: 22
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9162

No coin nor oath required. For personal study only.

✦ Synopsis

The mutation spectrum of the BRCA1 gene among ethnic groups from Asia has not been well studied. We investigated the frequency of mutations in the BRCA1 gene among Malay breast cancer patients from Singapore, independent of family history. By using the protein truncation test (PTT) and direct sequencing, BRCA1 mutations were detected in 6 of 49 (12.2%) unrelated patients. Four novel missense mutations in exon 11, T557A (1788A>G), T582A (1863A>G), N656S (2086A>G) and P684S (2169C>T) were identified in one patient. Two patients had missense mutations in exon 23, V1809A (5545T>C), which has been previously detected in individuals from Central and Eastern Europe. Three unrelated patients had the deleterious 2846insA frameshift mutation in exon 11. Methylation specific PCR (MSP) of the promoter region of the BRCA1 gene detected hypermethylation of tumor DNA in an additional 2 patients. Haplotype analysis using the microsatellite markers D17S855, D17S1323 and D17S1325 revealed a common haplotype for the three unrelated patients and their three relatives with the 2846insA mutation. These findings strongly suggest that the 2846insA mutation, the most common deleterious mutation in this study, may possibly be a founder mutation in breast cancer patients of Malay ethnic background.

📜 SIMILAR VOLUMES

Strong founder effects in BRCA1 mutation

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia

✍ Bela Csokay; Laima Tihomirova; Aivars Stengrevics; Olga Sinicka; Edith Olah 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB

Germ-line mutations of the BRCA1 gene account for approximately half of the cases of hereditary breast/ovarian cancers. We have screened index patients from 15 breast cancer families and 8 sporadic breast cancer patients from Latvia for mutations in all coding exons of the BRCA1 gene, using combined

Germline mutations in the BRCA1 and BRCA

Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients

✍ A. Esra Manguoǧlu; Güven Lüleci; Tayfun Özçelik; Taner Çolak; Hagit Schayek; Mus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w

Prevalence of founder BRCA1 and BRCA2 mu

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary

✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation

BRCA1 and BRCA2 mutations in breast/ovar

BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy

✍ L. Stuppia; P. Di Fulvio; G. Aceto; S. Pintor; S. Veschi; V. Gatta; A. Colosimo; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

We report on the screening of the entire BRCA1/BRCA2 coding sequence by SSCP, PTT, and direct sequencing in 68 Italian families with recurrent breast or ovarian cancer. For each investigated proband, the probability of being carrier of a BRCA1/BRCA2 mutation was evaluated using the BRCAPRO software.

BRCA2 gene mutations in Greek patients w

BRCA2 gene mutations in Greek patients with familial breast cancer

✍ Athanasios Armakolas; Angela Ladopoulou; Irene Konstantopoulou; B. Pararas; Ilia 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 2 views

Family history is a well-recognized risk factor for the development of breast cancer. The isolation of BRCA1 and BRCA2 genes, the two major predisposing genes in familial and to early onset breast and ovarian cancer, has resulted to the identification of a large number of families with mutations in

BRCA1 and BRCA2 mutations among breast c

BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines

✍ Maria Lourdes De Leon Matsuda; Alexander Liede; Elaine Kwan; Cynthia A. Mapua; E 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 2 views

## Abstract Age‐adjusted incidence rates of breast cancer vary more than 10‐fold worldwide, with the highest rates reported in North America and Europe. The highest breast cancer incidence rates in Southeast Asia have been reported for the Manila Cancer Registry in the Philippines, with an age‐stan